Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,041 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,668 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02312804 | Ph Ib/BGJ398/Cervix and Other Solid Tumors | withdrawn | Phase 1 | 0 | The University of Texas Health Science Center at San AntonioOTHER | 0 | Feb 16, 2015 | clinicaltrials |
| NCT02159690 | A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy | withdrawn | Phase 2 | 0 | Kenneth Pienta, MDOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT02065323 | A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT | withdrawn | Phase 2 | 0 | Oscar Goodman, Jr.OTHER | 1 | Jan 19, 2015 | clinicaltrials |
| NCT01492920 | Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy | withdrawn | Phase 3 | 0 | Gynecologic Oncology GroupNETWORK | 0 | Dec 31, 2014 | clinicaltrials |
| NCT01927393 | Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT01777230 | The Value of Preoperative Sentinel Lymph Node Mapping by Pelvic MR Lymphangiography and SPECT-CT in Cervical Cancer | withdrawn | — | 0 | UMC UtrechtOTHER | 1 | Dec 18, 2014 | clinicaltrials |
| NCT01838265 | Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management(MGM) | withdrawn | — | 0 | University of MiamiOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT00787488 | Pilot Study of IV and IP Chemotherapy Plus Abdominal Hyperthermia for Ovarian Ca | withdrawn | N/A | 0 | Mark DewhirstOTHER | 0 | Nov 11, 2014 | clinicaltrials |
| NCT01320787 | 18-F-Fluoroacetate as PET Imaging Agent | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 23, 2014 | clinicaltrials |
| NCT02017678 | Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin | withdrawn | Phase 2 | 0 | Andrea McCartOTHER | 1 | Sep 17, 2014 | clinicaltrials |
| NCT01943058 | Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer | withdrawn | Phase 2 | 0 | University of Southern CaliforniaOTHER | 0 | Sep 10, 2014 | clinicaltrials |
| NCT01606358 | Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer(IClyCO) | withdrawn | — | 0 | Rennes University HospitalOTHER | 1 | Aug 11, 2014 | clinicaltrials |
| NCT01550380 | BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers(BKM120) | withdrawn | Phase 2 | 0 | University of UtahOTHER | 1 | Jul 29, 2014 | clinicaltrials |
| NCT01688414 | Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer | withdrawn | N/A | 0 | Stanford UniversityOTHER | 0 | Jul 29, 2014 | clinicaltrials |
| NCT02054793 | Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC) | withdrawn | Phase 1 / Phase 2 | 0 | Emmanuel Antonarakis, MDOTHER | 1 | Jul 23, 2014 | clinicaltrials |
| NCT00610662 | Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia in Patients With An Abnormal Pap Smear | withdrawn | — | 0 | British Columbia Cancer AgencyOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT00874302 | Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms | withdrawn | Phase 3 | 0 | Repros Therapeutics Inc.INDUSTRY | 2 | Jun 27, 2014 | clinicaltrials |
| NCT01228942 | A Prospective Trial of COXEN Chemotherapy Prediction | withdrawn | N/A | 0 | University of VirginiaOTHER | 0 | Jun 6, 2014 | clinicaltrials |
| NCT00003094 | Carotenoid Rich Diet in Treating Cervical Dysplasia | withdrawn | Phase 2 | 0 | University of California, San DiegoOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT01743638 | MR-Guided Laser Ablation of Prostate Bed Recurrences | withdrawn | N/A | 0 | Mayo ClinicOTHER | 1 | Apr 10, 2014 | clinicaltrials |
| NCT01981668 | The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation | withdrawn | Phase 1 | 0 | Nova Scotia Cancer CentreOTHER | 0 | Mar 19, 2014 | clinicaltrials |
| NCT01734681 | Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | GenSpera, Inc.INDUSTRY | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00967928 | Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer | withdrawn | Phase 1 | 0 | Accelerated Community Oncology Research NetworkOTHER | 0 | Feb 14, 2014 | clinicaltrials |
| NCT01409473 | Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer(Prostate SBRT) | withdrawn | Phase 2 | 0 | Rocky Mountain Cancer CentersOTHER | 1 | Feb 12, 2014 | clinicaltrials |
| NCT01403103 | Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer | withdrawn | Early Phase 1 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Jan 17, 2014 | clinicaltrials |
| NCT00922129 | Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer | withdrawn | Phase 2 / Phase 3 | 0 | St. Joseph's Healthcare HamiltonOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT01131039 | Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer | withdrawn | Phase 2 | 0 | Emory UniversityOTHER | 0 | Dec 20, 2013 | clinicaltrials |
| NCT01982487 | Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission | withdrawn | Phase 1 / Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 0 | Dec 18, 2013 | clinicaltrials |
| NCT00768742 | Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study(FAST) | withdrawn | N/A | 0 | GynesonicsINDUSTRY | 1 | Nov 25, 2013 | clinicaltrials |
| NCT00681148 | Botulinum Toxin Injection With Prostate Brachytherapy | withdrawn | Phase 2 | 0 | Emory UniversityOTHER | 1 | Nov 21, 2013 | clinicaltrials |
| NCT00072540 | S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Nov 8, 2013 | clinicaltrials |
| NCT01617174 | Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer | withdrawn | — | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 0 | Nov 8, 2013 | clinicaltrials |
| NCT00110526 | Gene Therapy for Prostate Cancer That Returns After Radiation Therapy | withdrawn | Phase 1 | 0 | Simon HallOTHER | 0 | Oct 24, 2013 | clinicaltrials |
| NCT01481233 | Oral Colchicine in Men With Castrate Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | Milton S. Hershey Medical CenterOTHER | 0 | Sep 27, 2013 | clinicaltrials |
| NCT00382330 | Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox. | withdrawn | N/A | 0 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Sep 6, 2013 | clinicaltrials |
| NCT00085527 | FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer | withdrawn | Phase 2 | 0 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT01197209 | Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate Cancer | withdrawn | Phase 1 | 0 | Momotaro-Gene Inc.INDUSTRY | 1 | Aug 23, 2013 | clinicaltrials |
| NCT00084370 | Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy | withdrawn | N/A | 0 | University of Alabama at BirminghamOTHER | 1 | Aug 22, 2013 | clinicaltrials |
| NCT00685633 | Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer | withdrawn | Phase 2 | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | Aug 20, 2013 | clinicaltrials |
| NCT00017537 | Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer | withdrawn | Phase 1 | 0 | University of Alabama at BirminghamOTHER | 0 | Aug 5, 2013 | clinicaltrials |
| NCT00080639 | CA-125 in Screening Patients at High Risk for Ovarian Cancer | withdrawn | — | 0 | University of Alabama at BirminghamOTHER | 1 | Aug 5, 2013 | clinicaltrials |
| NCT00796874 | Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance | withdrawn | N/A | 0 | Roswell Park Cancer InstituteOTHER | 0 | Jul 25, 2013 | clinicaltrials |
| NCT00942838 | Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal Cavity(WAR) | withdrawn | Phase 1 | 0 | University of UtahOTHER | 1 | Jul 24, 2013 | clinicaltrials |
| NCT01899391 | Periperal Blood Lymphocytes During Prostate RT | withdrawn | — | 0 | University Health Network, TorontoOTHER | 0 | Jul 15, 2013 | clinicaltrials |
| NCT01498237 | Photoacoustic Endoscopy in Endometrial Cancer | withdrawn | Early Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Jul 11, 2013 | clinicaltrials |
| NCT00003517 | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer | withdrawn | Phase 2 | 0 | Burzynski Research InstituteOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00084565 | Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer | withdrawn | Phase 2 | 0 | Fox Chase Cancer CenterOTHER | 0 | Jul 10, 2013 | clinicaltrials |
| NCT00006267 | Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer | withdrawn | Phase 2 | 0 | Gynecologic Oncology GroupNETWORK | 0 | Jul 9, 2013 | clinicaltrials |
| NCT00369954 | Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin | withdrawn | Phase 2 | 0 | Gynecologic Oncology GroupNETWORK | 0 | Jun 10, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Feb 16, 2015source: clinicaltrials